Pharma Pressreleases

This section covers the managerial aspects in the Pharma industry.

West Introduces Verux™ Pharmaceutical Packaging Components in Asia Pacific Region

Friday, December 30, 2016

West Pharmaceutical Services Inc a global leader in innovative solutions for injectable drug administration today introduced the Verux line of pharmaceutical packaging components for the Asia Pacific market This dedicated brand of fitforpurpose stoppers and seals for injectable drug products provide..

American Health Council Names Charles Wade Dummer, MS to Industry Board

Friday, December 30, 2016
GLOBE NEWSWIRE

NEW YORK Dec 30 2016 GLOBE NEWSWIRE Mr Charles Wade Dummer has been selected to join the Industry Board at the American Health Council He will be sharing his knowledge and expertise on data analysis and visualization biomedical engineering patient risk management process validation and design ..

Abbott Acquisition of St. Jude Medical Set to Close on January 4, 2017

Friday, December 30, 2016
PR Newswire

ABBOTT PARK Ill Dec 30 2016 PRNewswire Abbott NYSE ABT announced today it intends to close the acquisition of St Jude Medical Inc on Wednesday Jan 4 2017 The announcement follows receipt of all regulatory clearances necessary for closing The transaction establishes Abbott as a leader in the med..

Bernstein Litowitz Berger & Grossmann LLP Announces Securities Class Action Suit Filed Against Alexion Pharmaceuticals, Inc. and Certain of Its Senior Executives

Friday, December 30, 2016
PR Newswire

NEW YORK Dec 30 2016 PRNewswire Bernstein Litowitz Berger Grossmann LLP BLBG today announced that it has filed a securities class action lawsuit on behalf of Boston Retirement System against Alexion Pharmaceuticals Inc Alexion or the Company NASDAQ ALXN and certain of its senior executives The ac..

TapImmune: Year End 2016 Update

Friday, December 30, 2016
PR Newswire

JACKSONVILLE Fla Dec 30 2016 PRNewswire TapImmune IncNASDAQ TPIV a clinicalstage immunooncology company specializing in the development of innovative peptide and genebased immunotherapeutics and vaccines for the treatment of cancer and metastatic disease today issued its yearend 2016 update ..

AXIM® Biotech Expands Advisory Board to Broaden the Development of Cannabinoids\' Therapeutic Indications

Thursday, December 29, 2016
GLOBE NEWSWIRE

NEW YORK Dec 29 2016 GLOBE NEWSWIRE AXIM Biotechnologies Inc AXIM Biotech OTCAXIM a world leader in biotechnology cannabinoid research and development announced today the addition of renowned Cardiac Anesthesiologist Dr Emil Engels MD MBA CPC Dr Emil Engel serves as Partner at Fairfax Anesthesio..

American Health Council Names Robin Stewart, PhD, RN, OCN, CCRC to Nursing Board

Thursday, December 29, 2016
GLOBE NEWSWIRE

NEW YORK Dec 29 2016 GLOBE NEWSWIRE Dr Robin Stewart Manager of Clinical Research at Lakeland Regional Health has been selected to join the Nursing Board at the American Health Council She will be sharing her knowledge and expertise in Oncology Clinical Research Nursing Clinical Trials and A..

Marij Pharmaceuticals, Inc. (“MariJ” or the “Company”), a wholly-owned subsidiary of Acacia Diversified Holdings, Inc. (“Acacia”) (OTCQB symbol: ACCA), begins manufacturing USDA Certified Organic hemp oil.

Thursday, December 29, 2016
GLOBE NEWSWIRE

Clearwater Florida Dec 29 2016 GLOBE NEWSWIRE MariJ a certified organic mobile CO2 processor and handler has entered into a processing agreement with a certified organic hemp farm in Colorado allowing our Company to produce what we believe to be some of the first certified CO2 organic hem..

Mylan Launches Generic Cerebyx® Injection

Thursday, December 29, 2016
PR Newswire

HERTFORDSHIRE England and PITTSBURGH Dec 29 2016 PRNewswire Mylan NV NASDAQ TASE MYL today announced the US launch of Fosphenytoin Sodium Injection USP 75 mgmL 50 mg PEmL packaged in 100 mg PE2 mL and 500 mg PE10 mL singleuse vials a generic version of Pfizers Cerebyx Injection Mylan received fina..

Mallinckrodt plc To Report Earnings Results For Transition Period Of Oct. 1, 2016, To Dec. 30, 2016, On Feb. 7, 2017

Thursday, December 29, 2016
PR Newswire

STAINESUPONTHAMES United Kingdom Dec 29 2016 PRNewswire Mallinckrodt Pharmaceuticals NYSE MNK a leading global specialty pharmaceutical company announced today it will report earnings results for the transition period of Oct 1 2016 to Dec 30 2016 on Tuesday Feb 7 2017 ..

Research Reports Initiation on Biotech Stocks -- Incyte, Anavex Life Sciences, Portola Pharma, and Spectrum Pharma

Thursday, December 29, 2016
PR Newswire

NEW YORK December 29 2016 PRNewswire StockCallerscom brings focus on Biotechnology which is defined as the manipulation of living organisms or their components to produce useful commercial products such as pest resistant crops new bacterial strains or novel pharmaceuticals Equities in todays lin..

NFI Consumer Healthcare Completes Acquisition of OTC Brand e.p.t® from Prestige Brands Holdings, Inc.

Thursday, December 29, 2016
PR Newswire

BRISTOL Tenn Dec 29 2016 PRNewswire NFI Consumer Healthcare announces the acquisition of ept the OverTheCounter OTC pregnancy test kit brand from Prestige Brands Holdings Inc NYSE PBH NFI Consumer Healthcare NFI a division of Gregory Pharmaceutical Holdings GPH has en..

Intrexon Announces a Special Stock Dividend of Shares of AquaBounty Technologies

Thursday, December 29, 2016
PR Newswire

GERMANTOWN Md Dec 29 2016 PRNewswire Intrexon Corporation NYSE XONIntrexon or the Company a leader in the engineering and industrialization of biology to improve the quality of life and health of the planet today announced a special stock dividend of 53296710 shares of common stock of AquaBoun..

Intarcia Secures Second Close of the Series EE Equity Financing for an Additional $206M; As Part of the Financing and a New Strategic Initiative, Intarcia Now Aims Its Medici Technology Towards Preventing HIV

Thursday, December 29, 2016
PR Newswire

BOSTON Dec 29 2016 PRNewswire Intarcia Therapeutics Inc today announced it has completed its second major close of the Series EE equity financing and also entered into a relationship with the Bill Melinda Gates Foundation to help prevent the spread of HIV in SubSaharan Africa and other countries..

Medivir Completes Previously Announced Oncology Programs Acquisition

Thursday, December 29, 2016
PR Newswire

STOCKHOLM Sweden Dec 29 2016 PRNewswire Medivir AB Nasdaq Stockholm MVIR today announces that the acquisitions of the two clinical stage oncology programs from TetraLogic Pharmaceuticals Corporation Nasdaq TLOG have been completed In connection with the closing Medivir has paid the upfront pay..

RxWiki Launches First Ever Patient Verified Reviews for 1400+ Pharmacy Brands

Thursday, December 29, 2016
PR Newswire

AUSTIN Texas Dec 29 2016 PRNewswire RxWiki Inc a digital health company that powers the websites mobile apps and digital marketing strategies of thousands of pharmacies through its Digital Pharmacist SaaS platform today announced that it has launched Patient Verified Reviews Patients can now rat..

Cornerstone Pharmaceuticals to Present at 9th Annual Biotech Showcase™ in San Francisco, January 9-11, 2017

Thursday, December 29, 2016
PR Newswire

CRANBURY NJ Dec 29 2016 PRNewswire WHAT Cornerstone Pharmaceuticals will present to investors and biopharmaceutical executives from around the world The 9th Annual Conference Biotech Showcase is one of the largest annual healthcare conferences around the world and will take place in San Francis..

Mylan Launches Generic Concerta® Tablets

Thursday, December 29, 2016
PR Newswire

HERTFORDSHIREEngland and PITTSBURGH Dec 29 2016 PRNewswire Mylan NV NASDAQ TASE MYL today announced the US launch of Methylphenidate Hydrochloride ExtendedRelease Tablets USP 18 mg 27 mg 36 mg and 54 mg a generic version of Janssens Concerta Tablets Mylan received final approval from the US Food a..

Escend Pharmaceuticals, Inc., Receives Second Orphan Drug Designation from FDA for ES-3000

Wednesday, December 28, 2016
PR Newswire

MENLO PARK Calif Dec 28 2016 PRNewswire Escend Pharmaceuticals Inca privately held company focused on the development of small molecule therapeutics for oncology orphan diseases announced today that the FDA Office of Orphan Products Development OOPD has granted orphan drug designation for its lead..

Achillion Announces Clinical Milestone for the Advancement of JNJ-4178 in Phase 2B Development for Chronic HCV

Wednesday, December 28, 2016
GLOBE NEWSWIRE

NEW HAVEN Conn Dec 28 2016 GLOBE NEWSWIRE Achillion Pharmaceuticals IncNasdaqACHN today announced that it has received a 15 million milestone payment from Janssen Research Development LLC part of the Janssen Pharmaceutical Companies of Johnson Johnson Janssen related to enrollment in the OME..

TOP